Rose Beck, MD, PhD, is an accomplished biomarker pathologist currently serving as the Associate Vice President of Diagnostics Development at Eli Lilly and Company. With a rich background in translational and clinical research, Rose contributed to the field from positions at Case Western Reserve University School of Medicine and University Hospitals, where they specialized in hematopathology. Previously, Rose held roles as Executive Director at Eli Lilly Clinical Diagnostics Laboratory and Associate Medical Director at Seagen, focusing on biomarker strategies for cancer therapies. Rose obtained an MD and PhD in Medicine from Case Western Reserve University School of Medicine in 2001.
This person is not in any teams
This person is not in any offices